Baidu
map

ESC 2013:真实世界研究发现采用血栓抽吸并不减少PCI后患者的1年生存率(FAST-MI2010注册研究)

2013-09-03 MedSci MedSci原创

  背景:ST段抬高心肌梗死(STEMI)时采用血栓抽吸行直接PCI是否会增加患者的死亡率仍是一个存在争议的问题。该研究评估了FAST-MI 2010注册研究中行直接PCI时应用了血栓抽吸的STEMI患者的1年生存率。   方法:FAST-MI 2010研究是法国的一项全国性注册研究,共计在2010年末从213家中心入选41 169例急性心肌梗死(AMI)患者,其中2438例伴有STEM

  背景:ST段抬高心肌梗死(STEMI)时采用血栓抽吸行直接PCI是否会增加患者的死亡率仍是一个存在争议的问题。该研究评估了FAST-MI 2010注册研究中行直接PCI时应用了血栓抽吸的STEMI患者的1年生存率。

  方法:FAST-MI 2010研究是法国的一项全国性注册研究,共计在2010年末从213家中心入选41 169例急性心肌梗死(AMI)患者,其中2438例伴有STEMI或左束支传导阻滞。上述患者中有1497例进行了直接PCI,其中663例(44%) 应用了血栓抽吸。

  结果:与未应用者相比,应用了血栓抽吸的患者更年轻(61岁 vs. 63岁,P=0.01),GRACE评分相当(140 vs. 143,P=0.10),发病持续时间更短( 245 分钟vs. 285分钟,P=0.001),更多到学院型医院就诊(46% vs. 35%,P<0.001);但AMI部位、MI/ PCI/CABG病史无显著差异。此外,应用及未应用血栓抽吸者30天内死亡率(2.1% vs. 2.3%,P=0.71)及1年生存率(95.5% vs. 94.8%,P=0.59)均无显著差异。Cox多因素分析结果显示,与未应用者相比,应用血栓抽吸者1年内死亡的校正后HR为1.02(95%CI:0.54~1.91,P=0.96)。计算血栓抽吸的倾向评分,并对基线特征相似的两组各550例患者进行对比分析。结果发现,应用与未应用血栓抽吸者30天死亡率(1.1% vs. 1.5%,P=0.59)及1年生存率(96.4% vs. 96.2%,P=0.90)均无差异。

  结论:在真实世界环境中应用血栓抽吸并不能改善患者的一年生存率。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
    2014-06-24 JR19860219
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
    2014-02-21 gracezdd
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2016026, encodeId=c93e201602670, content=<a href='/topic/show?id=bb11e25425' target=_blank style='color:#2F92EE;'>#FAST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7254, encryptionId=bb11e25425, topicName=FAST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20b5274, createdName=JR19860219, createdTime=Tue Jun 24 06:04:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057887, encodeId=b388205e887be, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Fri Feb 21 20:04:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710658, encodeId=d37e1e10658d8, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sun Apr 27 17:04:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753018, encodeId=20351e53018e4, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Aug 12 02:04:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641489, encodeId=bbc9164148909, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Mon Jun 16 10:04:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764744, encodeId=4dce1e64744e0, content=<a href='/topic/show?id=c73964968de' target=_blank style='color:#2F92EE;'>#注册研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64968, encryptionId=c73964968de, topicName=注册研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510b37798730, createdName=dlwang_26703139, createdTime=Fri Jun 20 10:04:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256474, encodeId=708412564e407, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295142, encodeId=28a91295142d5, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556703, encodeId=d7e21556e03f9, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Thu Sep 05 13:04:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
    2013-09-05 zhyy93

相关资讯

ESC 2013:CHADS2 风险评分显示超过1/3房颤患者无需抗凝治疗

  2013年8月31日ESC 2013年会现场来自德国的Michael Nabauer教授等人的研究显示,超过三分之一的心房颤动(AF)患者CHADS2卒中风险评分为0 或1,属于低危或中危患者,无需强制进行口服抗凝治疗。相比之下,CHA2DS2-VASc评分为0,则能识别出不能从抗凝治疗中获益的具有极低危卒中风 险的患者。   Nabauer教授指出,AF是最常见的需要住院治疗的心

ESC 2013:无晚期心力衰竭症状的患者心脏再同步化能明显获益(MADIT-CRT研究)

  背景: MADIT-CRT研究显示,心脏再同步治疗除颤器(CRT-D)能显著降低入选研究前至少3个月伴有轻度心力衰竭(HF)症状(NYHA 分级为I级或II级)患者的HF或死亡风险。该研究旨在评估CRT-D对入选研究前既往任何时间伴有晚期HF症状病史的患者的益处。   方法:于入选研究前任意时间均无晚期HR病史(NYHA分级≥III级或既往曾因HF恶化而住院)的患者(I组)及既往伴有

ESC 2013:运动诱导的循环高敏肌钙蛋白T变化对稳定性胸痛患者的诊断价值

  背景:心肌肌钙蛋白T(cTnT)是心肌坏死的标志物,但其是否是可逆性缺血的标志物尚存争议。该研究旨在评估测定运动试验前及运动试验后20小时的cTnT能否改善对稳定性胸痛患者的诊断评估。   方法:入选157例可疑冠状动脉疾病(CAD)患者,收集其限制性运动试验前及试验后20小时的血样。采用 CT冠脉造影和/或冠脉造影评估冠状动脉的解剖情况,并将患者分为以下四组:①无钙化组(n=65),②钙

ESC 2013:Eugene Braunwald教授总结心脏病学领域十大历史事件

  1、心电图:1903荷兰的Willem Einthoven首次应用弦线电流仪通过记录心脏的心电活动记录了人类的心电图,并以P、Q、R、S和T等字母表示不同的波段来描述心血管疾病的心电图 变化,现代心脏病学由此诞生。随后,在短短几年内,ECG得到了广泛的应用。   2、心导管插入术:19世纪法国生理学家Claude Bernard首先插入导管测量了动物心脏心腔及大血管的压力。1929

ESC 2013:单用药物治疗的稳定性冠心病患者的FAME 2 总缺血风险评分与临床结局

  目的:该研究旨在观察总缺血与稳定性冠心病患者临床结局的相关性。   方法:该研究是对FAME 2 研究中的607例至少一支主要冠状动脉存在病变、仅接受药物治疗(MT)的患者进行了亚组分析。这些患者中,有441例患者来自于随机试验,166例患者 来自于注册研究。分析心血管死亡、心肌梗死及缺血所致的靶病变血运重建(MACE)的复合终点发生率及其与FAME 2 总缺血风险评分的相关性,应

ESC 2013:心脏再同步化治疗对窄QRS波(<120 ms)患者无获益(EARTH研究)

  背景:虽然研究业已证实心脏再同步治疗(CRT)能使QRS间期延长的患者获益,但在窄QRS波患者中其是否具有益处尚不确定。   方法:EARTH试验由两个并行的多中心随机双盲临床试验研究组成,旨在观察CRT对QRS ≥ 120 ms及QRS< 120 ms患者的作用。两项研究的入选标准是:具有植入除颤仪的临床适应证,左室射血分数(LVEF)≤35%以及6分钟步行试验中6分钟步行距

Baidu
map
Baidu
map
Baidu
map